Cargando…

Influence of pharmacist intervention on drug safety of geriatric inpatients: a prospective, controlled trial

BACKGROUND: Demographic shift leads to an increasing number of geriatric patients suffering from multimorbidity and resulting polypharmacy. Polypharmacy is shown to be associated with drug-related problems (DRPs) and increased morbidity. For Germany, a hospital-based intervention may be successful o...

Descripción completa

Detalles Bibliográficos
Autores principales: Nachtigall, Angela, Heppner, Hans J., Thürmann, Petra A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6469284/
https://www.ncbi.nlm.nih.gov/pubmed/31019678
http://dx.doi.org/10.1177/2042098619843365
_version_ 1783411616204718080
author Nachtigall, Angela
Heppner, Hans J.
Thürmann, Petra A.
author_facet Nachtigall, Angela
Heppner, Hans J.
Thürmann, Petra A.
author_sort Nachtigall, Angela
collection PubMed
description BACKGROUND: Demographic shift leads to an increasing number of geriatric patients suffering from multimorbidity and resulting polypharmacy. Polypharmacy is shown to be associated with drug-related problems (DRPs) and increased morbidity. For Germany, a hospital-based intervention may be successful optimizing of polypharmacy. The aim of this study was to reduce DRPs in geriatric inpatients by a structured pharmacist’s intervention and to measure the acceptance rate of pharmaceutical recommendations. METHODS: This study followed an open, prospective, quasi-randomized, controlled design and was conducted in a geriatric department in a teaching hospital in Germany. Patients of all sexes were included, with a minimum age of 70 years, a written informed consent and a regular intake of at least five drugs daily. Primary outcome was the percentage of patients having a DRP at admission and discharge. A DRP was defined as a prescription without indication or a relevant drug–drug interaction or prescription of a potentially inappropriate medication or presence of an adverse drug reaction. Recommendations were classified and discussed face to face. Statistical analyses were performed using a full-set analysis and a matched-pairs design. RESULTS: Within 12 months, 411 patients were recruited with median age of 82 years (intervention: n = 209; control: n = 202). Median number of drugs at admission was 10 (range 5–24), at discharge 9 (range 3–21). In the intervention group, the percentage of patients with a DRP was reduced from 86.6% to 56.0%; in the control group, from 76.7% to 76.2% (p value < 0.001). Medication appropriateness index score was reduced by 56% in the intervention group and by 0.2% in the control group (p value < 0.001). Implementation rate of the pharmaceutical recommendation was 80%. CONCLUSION: This prospective controlled trial showed that a pharmacist’s intervention was successful in optimizing polypharmacy in geriatric inpatients.
format Online
Article
Text
id pubmed-6469284
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher SAGE Publications
record_format MEDLINE/PubMed
spelling pubmed-64692842019-04-24 Influence of pharmacist intervention on drug safety of geriatric inpatients: a prospective, controlled trial Nachtigall, Angela Heppner, Hans J. Thürmann, Petra A. Ther Adv Drug Saf Original Research BACKGROUND: Demographic shift leads to an increasing number of geriatric patients suffering from multimorbidity and resulting polypharmacy. Polypharmacy is shown to be associated with drug-related problems (DRPs) and increased morbidity. For Germany, a hospital-based intervention may be successful optimizing of polypharmacy. The aim of this study was to reduce DRPs in geriatric inpatients by a structured pharmacist’s intervention and to measure the acceptance rate of pharmaceutical recommendations. METHODS: This study followed an open, prospective, quasi-randomized, controlled design and was conducted in a geriatric department in a teaching hospital in Germany. Patients of all sexes were included, with a minimum age of 70 years, a written informed consent and a regular intake of at least five drugs daily. Primary outcome was the percentage of patients having a DRP at admission and discharge. A DRP was defined as a prescription without indication or a relevant drug–drug interaction or prescription of a potentially inappropriate medication or presence of an adverse drug reaction. Recommendations were classified and discussed face to face. Statistical analyses were performed using a full-set analysis and a matched-pairs design. RESULTS: Within 12 months, 411 patients were recruited with median age of 82 years (intervention: n = 209; control: n = 202). Median number of drugs at admission was 10 (range 5–24), at discharge 9 (range 3–21). In the intervention group, the percentage of patients with a DRP was reduced from 86.6% to 56.0%; in the control group, from 76.7% to 76.2% (p value < 0.001). Medication appropriateness index score was reduced by 56% in the intervention group and by 0.2% in the control group (p value < 0.001). Implementation rate of the pharmaceutical recommendation was 80%. CONCLUSION: This prospective controlled trial showed that a pharmacist’s intervention was successful in optimizing polypharmacy in geriatric inpatients. SAGE Publications 2019-04-16 /pmc/articles/PMC6469284/ /pubmed/31019678 http://dx.doi.org/10.1177/2042098619843365 Text en © The Author(s), 2019 http://www.creativecommons.org/licenses/by-nc/4.0/ This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 License (http://www.creativecommons.org/licenses/by-nc/4.0/) which permits non-commercial use, reproduction and distribution of the work without further permission provided the original work is attributed as specified on the SAGE and Open Access pages (https://us.sagepub.com/en-us/nam/open-access-at-sage).
spellingShingle Original Research
Nachtigall, Angela
Heppner, Hans J.
Thürmann, Petra A.
Influence of pharmacist intervention on drug safety of geriatric inpatients: a prospective, controlled trial
title Influence of pharmacist intervention on drug safety of geriatric inpatients: a prospective, controlled trial
title_full Influence of pharmacist intervention on drug safety of geriatric inpatients: a prospective, controlled trial
title_fullStr Influence of pharmacist intervention on drug safety of geriatric inpatients: a prospective, controlled trial
title_full_unstemmed Influence of pharmacist intervention on drug safety of geriatric inpatients: a prospective, controlled trial
title_short Influence of pharmacist intervention on drug safety of geriatric inpatients: a prospective, controlled trial
title_sort influence of pharmacist intervention on drug safety of geriatric inpatients: a prospective, controlled trial
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6469284/
https://www.ncbi.nlm.nih.gov/pubmed/31019678
http://dx.doi.org/10.1177/2042098619843365
work_keys_str_mv AT nachtigallangela influenceofpharmacistinterventionondrugsafetyofgeriatricinpatientsaprospectivecontrolledtrial
AT heppnerhansj influenceofpharmacistinterventionondrugsafetyofgeriatricinpatientsaprospectivecontrolledtrial
AT thurmannpetraa influenceofpharmacistinterventionondrugsafetyofgeriatricinpatientsaprospectivecontrolledtrial